A proposed $4.8 billion agreement crafted to settle a majority of the remaining Vioxx-related lawsuits against Merck has drawn more than 44,000 plaintiffs, meeting a critical early requirement for the settlement to go into effect.
Lawyer Central Also Recommends These Stories: